Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystander?

被引:29
作者
Charikleia, Christakou [1 ]
Frangiskos, Economou [1 ]
Sarantis, Livadas [1 ]
Christina, Piperi [2 ]
Christos, Adamopoulos [2 ]
Evangelos, Marinakis [1 ]
Evanthia, Diamanti-Kandarakis [1 ]
机构
[1] Univ Athens, Sch Med, Dept Internal Med 3, Endocrine Unit, Athens 11528, Greece
[2] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2011年 / 10卷 / 04期
关键词
Advanced glycation end products; Endothelin-1; PCOS; Androgens; Insulin resistance; POLYCYSTIC-OVARY-SYNDROME; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; POSTMENOPAUSAL WOMEN; PLASMA-LEVELS; RECEPTOR; ENDPRODUCTS; RISK;
D O I
10.14310/horm.2002.1320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Advanced glycation end products (AGEs) activate the intracellular Nuclear Factor-kappa B pathway in endothelial cells, leading to production of endothelin-1 (ET-1), a peptide which causes endothelial dysfunction. The aim of the present study was to assess ET-1 and AGEs levels in women with polycystic ovary syndrome (PCOS) and controls and to investigate any potential relationship between them. DESIGN: Metabolic and hormonal data from 75 women with PCOS and 25 controls, matched for age and BMI were analyzed and correlated to AGEs and ET-1 levels. RESULTS: Serum levels of ET-1 (1.55 +/- 0.13 vs. 0.37 +/- 0.10 pmol/l, p:0.003) and AGEs (8.34 +/- 1,81 vs. 5.77 +/- 0.78U/ml, p:0.002) were significantly higher in the PCOS group. ET-1 was correlated with AGES (r:0.54, p < 0.001), Testosterone (r:0.38, p < 0.001), Delta A4 (r:0.41, p < 0.001) and FAI (r:0.21, p < 0.05). However, multiple linear regression analysis in the total study population showed that ET-1 was positively associated only with AGES (beta:0.22, p < 0.001). CONCLUSIONS: ET-1 levels were positively and strongly associated with AGEs in both PCOS women and controls, suggesting that the detrimental effect of AGEs on endothelial cells may involve increased ET-1 production.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 34 条
[1]   Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[2]   Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications [J].
Basta, Giuseppina .
ATHEROSCLEROSIS, 2008, 196 (01) :9-21
[3]   The importance of endothelin-1 for vascular dysfunction in cardiovascular disease [J].
Boehm, Felix ;
Pernow, John .
CARDIOVASCULAR RESEARCH, 2007, 76 (01) :8-18
[4]   IDENTIFICATION OF THE MAJOR SITE OF APOLIPOPROTEIN-B MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS BLOCKING UPTAKE BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR [J].
BUCALA, R ;
MITCHELL, R ;
ARNOLD, K ;
INNERARITY, T ;
VLASSARA, H ;
CERAMI, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10828-10832
[5]   Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients [J].
Chiang, Kuang-Hsing ;
Huang, Po-Hsun ;
Huang, Shao-Sung ;
Wu, Tao-Cheng ;
Chen, Jaw-Wen ;
Lin, Shing-Jong .
CORONARY ARTERY DISEASE, 2009, 20 (04) :267-273
[6]  
de Groot PCM, 2011, HUM REPROD UPDATE
[7]   Oxidative stress and aging: Is methylglyoxal the hidden enemy? [J].
Desai, Kaushik M. ;
Chang, Tuanjie ;
Wang, Hui ;
Banigesh, Ali ;
Dhar, Arti ;
Liu, Jianghai ;
Untereiner, Ashley ;
Wu, Lingyun .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2010, 88 (03) :273-284
[8]   Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome [J].
Diamanti-Kandarakis, E ;
Piperi, C ;
Kalofoutis, A ;
Creatsas, G .
CLINICAL ENDOCRINOLOGY, 2005, 62 (01) :37-43
[9]   Metformin administration improves endothelial function in women with polycystic ovary syndrome [J].
Diamanti-Kandarakis, E ;
Alexandraki, K ;
Protogerou, A ;
Piperi, C ;
Papamichael, C ;
Aessopos, A ;
Lekakis, J ;
Mavrikakis, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (05) :749-756
[10]   Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy [J].
Diamanti-Kandarakis, E ;
Spina, G ;
Kouli, C ;
Migdalis, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4666-4673